echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Industry "Internal Volume": 1500+ Medical Personnel Focused on Source Innovation in Shanghai in March - Antibody

    Industry "Internal Volume": 1500+ Medical Personnel Focused on Source Innovation in Shanghai in March - Antibody

    • Last Update: 2022-03-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to statistics, in 2021, the FDA has approved a total of 8 new antibody drugs, and a total of 107 new antibody drugs have been approved, including 2 ADC drugs


    Based on this, the 9th BioCon China International Biopharmaceutical Conference and Exhibition will launch a series of high-quality BioCon-Antibody thematic forums (the 9th International Biopharmaceutical Conference Series-Antibody Special Forum) in Shanghai on March 22-23 this year .


    The first batch of guests to watch first-antibody

    Dimiter S.


    Conference Highlights and Structure

    Forum Highlights


    Forum Structural


    Register for tickets before February 25, 2022 to enjoy an early bird discount and an instant discount of RMB 500!

    There is also a Lantern Festival group activity, where 5 people form a group to enjoy a surprise group price


    For more meeting details, please contact: 180 1793 9885 (same number on WeChat)

    BioCon-Antibody Sponsor/Exhibitor Recruitment

    Keynote speech, booth sponsorship, exclusive dinner/bag/hangtag/chairback sponsorship, press release and other sponsorship forms are available for you to showcase innovative drug discovery, development, druggability/development of antibodies/proteins/conjugates Quality solutions such as performance evaluation, process quality and CMC!


    The three sessions will be jointly built at the same time

    In recent years, in drug development, the proven target/structure/indication has become a red ocean, and the industry's "introduction" will become a shackle.


    List of concurrent forums:

    ClinCon 2022 The 2nd Innovative Drug Clinical Translation and Development Forum

    Forum highlights:


    PharmaCon 2022 The 8th China International Chemical Drug R&D Forum

    Forum Highlights


    Welcome to contact the Organizing Committee for details of the agenda/sponsorship/speech/media, etc.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.